-
282022.01
SCM Life Science, Cha Biotech Production of cell therapy and establish..
SCM Life Science (SCM Life Science, KOSDAQ 298060, CEO Lee Byung-gun), a company specializing in cell therapy, has sign..
-
282022.01
SCM Life Science, Completed administration of the first patient in pha..
SCM Life Science (SCM Life Science, KOSDAQ 298060, CEO Lee Byung-gun), a company specializing in cell therapy, On the ..
-
282022.01
SCM Life Science, has registered two patents for key original technolo..
SCM Life Science (SCM Life Science, KOSDAQ 298060, CEO Lee Byung-gun), a company specializing in cell therapy, announce..
-
282022.01
SCM Life Science, officially invited to the JPMorgan Healthcare Confer..
SCM Life Science (SCM Life Science, CEO Lee Byung-gun), Korea's leading cell therapy company, was officially invited to..
-
282022.01
SCM Life Science, Announces Interim Results of Phase 1/2 Clinical Atop..
SCM Life Science (SCM Life Science, KOSDAQ 298060, CEO Lee Byung-gun), a company specializing in cell therapy, On the ..
-
282022.01
SCM Life Science-Genexine, Published interim results of clinical trial..
Coimune, a U.S. joint venture between Scm Life Science (298060, CEO Lee Byung-gun) and Genexine (095700, CEO Sung Young..
-
282022.01
SCM Life Science, Acquired a patent for the next generation of stem ce..
SCM Life Science (KOSDAQ 298060. CEO Lee Byung-gun) announced on the 7th that it recently registered a patent (registra..
-
282022.01
SCM Life Science, Completed the administration of phase 1 clinical tri..
SCM Life Science (KOSDAQ 298060. SCM Life Science CEO Lee Byung-gun) announced on the 15th that the administration of p..
-
282022.01
SCM Life Science, Designation of Rare medicine in the Development Stag..
Acute pancreatitis stem cell therapy (SCM-AGH) of SCM Life Science (KOSDAQ 298060 CEO Lee Byung-gun, hereinafter SCM L..